9:37 AM
 | 
Apr 12, 2018
 |  BC Extra  |  Financial News

Tessa raises additional $50M, names Ando to board

Immunotherapy company Tessa Therapeutics Pte. Ltd. (Singapore) added $50 million to a financing round announced in December, bringing the round's total to $130 million.

The company also named former Novo Nordisk A/S (CSE:NOVOB;...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >